Lakhmir S. Chawla serves as Executive at LA JOLLA PHARMACEUTICAL CO, where they oversee executive responsibilities. Since joining the company, Lakhmir S. Chawla has executed 57 insider transactions totaling $85.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 30, 2018 involved receiving (via award) 16 shares valued at $197.
Lakhmir S. Chawla currently holds 12,158 shares of LA JOLLA PHARMACEUTICAL CO (LJPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lakhmir S. Chawla has been a net buyer of LJPC stock. They have purchased $85.8K and sold $0 worth of shares.
Lakhmir S. Chawla's most recent insider trade was on Nov 30, 2018, when they sold 16 shares at $12.30 per share.
Get notified when new Form 4 filings are submitted
| $12.67 |
| Discretionary |
| Oct 31, 2018 | LJPC | $208 | Award | 15 | $13.86 | Discretionary |
| Oct 15, 2018 | LJPC | $207 | Award | 15 | $13.81 | Discretionary |
| Mar 3, 2017 | LJPC | $34.5K | Purchase | 1,000 | $34.48 | Discretionary |
| Mar 2, 2017 | LJPC | $21.2K | Purchase | 600 | $35.33 | Discretionary |
| Sep 28, 2015 | LJPC | $13.5K | Purchase | 485 | $27.75 | Discretionary |